ArticleThoracic cancer2024

Correction to "Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.